{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T04:53:02Z","timestamp":1795150382343,"version":"4.10.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Varying degrees of macular ischemia generally occur in diabetic retinopathy (DR). This study aims to evaluate the effect of conbercept with 3+ pro re nata (PRN) on macular perfusion status in patients with diabetic macular edema (DME) and quantitatively assess changes in foveal avascular zone (FAZ) areas and capillary density in macular regions by applying optical coherence tomography angiography (OCTA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Fifty patients were divided into ischemic (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u200931) and non-ischemic (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u200919) groups according to the presence of ischemia on OCTA at baseline. All patients received intravitreal injections of 0.5\u2009mg of conbercept with 3+ PRN principle. The FAZ areas and macular vessel density measured using OCTA were evaluated at baseline, 3\u2009months, and 6\u2009months after treatment in both groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At months 3 and 6, the FAZ area in the ischemic group changed from 0.510\u2009\u00b1\u20090.171\u2009mm\n                      <jats:sup>2<\/jats:sup>\n                      to 0.441\u2009\u00b1\u20090.158\u2009mm\n                      <jats:sup>2<\/jats:sup>\n                      then to 0.427\u2009\u00b1\u20090.153\u2009mm\n                      <jats:sup>2<\/jats:sup>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.003,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.296); in the non-ischemic group, it remained stable (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.269,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.926). The superficial vessel density changed from 41.1\u2009\u00b1\u20094.1 to 42.5%\u2009\u00b1\u20094.7% then to 42.6%\u2009\u00b1\u20094.6% (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.043,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.812), and the deep vessel density changed from 40.7\u2009\u00b1\u20094.4 to 42.3%\u2009\u00b1\u20093.6% then to 42.3%\u2009\u00b1\u20094.7% (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.072,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.961) in the ischemic group. In the non-ischemic group, the superficial vessel density changed from 44.8\u2009\u00b1\u20093.2 to 46.0%\u2009\u00b1\u20093.5% then to 45.7%\u2009\u00b1\u20093.3% (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.108,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.666), whereas the deep vessel density changed from 43.6\u2009\u00b1\u20093.6 to 43.8%\u2009\u00b1\u20093.2% then to 43.5%\u2009\u00b1\u20094.5% (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.882,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.736). Reperfusion in macular nonperfusion areas was observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Anti\u2013vascular endothelial growth factor treatment may have a positive effect on macular perfusion status. Furthermore, OCTA had advantages in quantifying and calculating blood flow index in the study of macular perfusion status.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-020-01648-x","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T09:04:16Z","timestamp":1601024656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical effect of conbercept on improving diabetic macular ischemia by OCT angiography"],"prefix":"10.1186","volume":"20","author":[{"given":"Ziyi","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youling","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhishang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejun","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8905-9388","authenticated-orcid":false,"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,25]]},"reference":[{"issue":"9","key":"1648_CR1","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/bjo.75.9.514","volume":"75","author":"O Arend","year":"1991","unstructured":"Arend O, et al. Retinal microcirculation in patients with diabetes mellitus: dynamic and morphological analysis of perifoveal capillary network. Br J Ophthalmol. 1991;75(9):514\u20138..","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"1648_CR2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4274\/tjo.galenos.2018.19616","volume":"49","author":"NG Yalcin","year":"2019","unstructured":"Yalcin NG, Ozdek S. The relationship between macular cyst formation and ischemia in diabetic macular edema. Turk J Ophthalmol. 2019;49(4):194\u2013200.","journal-title":"Turk J Ophthalmol"},{"key":"1648_CR3","doi-asserted-by":"crossref","unstructured":"Early Treatment Diabetic Retinopathy Study Research Group. Classification of diabetic retinopathy from fluorescein angiograms: ETDRS report number 11. Ophthalmology. 1991;98(5 Suppl):807\u201322.","DOI":"10.1016\/S0161-6420(13)38013-0"},{"issue":"7","key":"1648_CR4","first-page":"e3064","volume":"10","author":"M Usman","year":"2018","unstructured":"Usman M. An overview of our current understanding of diabetic macular ischemia (DMI). Cureus. 2018;10(7):e3064.","journal-title":"Cureus"},{"issue":"6","key":"1648_CR5","first-page":"1202","volume":"8","author":"JK Li","year":"2015","unstructured":"Li JK, et al. Changes in vitreous VEGF, bFGF and fibrosis in proliferative diabetic retinopathy after intravitreal bevacizumab. Int J Ophthalmol. 2015;8(6):1202\u20136.","journal-title":"Int J Ophthalmol"},{"issue":"6","key":"1648_CR6","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.ajo.2009.01.009","volume":"147","author":"M Bonini-Filho","year":"2009","unstructured":"Bonini-Filho M, et al. Intravitreal bevacizumab for diabetic macular edema associated with severe capillary loss: one-year results of a pilot study. Am J Ophthalmol. 2009;147(6):1022\u201330 1030.e1\u20135.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1648_CR7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/jamaophthalmol.2017.6135","volume":"136","author":"SG Karst","year":"2018","unstructured":"Karst SG, et al. Association of Changes in macular perfusion with Ranibizumab treatment for diabetic macular edema: a subanalysis of the RESTORE (extension) study. JAMA Ophthalmol. 2018;136(4):315\u201321.","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"1648_CR8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/IAE.0000000000002422","volume":"39","author":"S Bonnin","year":"2019","unstructured":"Bonnin S, et al. Anti-vascular endothelial growth factor therapy can improve diabetic retinopathy score without change in retinal perfusion. Retina. 2019;39(3):426\u201334.","journal-title":"Retina"},{"key":"1648_CR9","doi-asserted-by":"crossref","unstructured":"Couturier A, et al. Widefield OCT-angiography and fluorescein angiography assessments of nonperfusion in diabetic retinopathy and edema treated with anti-vascular endothelial growth factor. Ophthalmology. 2019;126(12):1685\u201394.","DOI":"10.1016\/j.ophtha.2019.06.022"},{"issue":"10","key":"1648_CR10","doi-asserted-by":"crossref","first-page":"p1568","DOI":"10.1016\/j.ophtha.2018.04.002","volume":"125","author":"RK Reddy","year":"2018","unstructured":"Reddy RK, et al. Efficacy of ranibizumab in eyes with diabetic macular edema and macular nonperfusion in RIDE and RISE. Ophthalmology. 2018;125(10):p1568\u201374.","journal-title":"Ophthalmology"},{"key":"1648_CR11","doi-asserted-by":"crossref","unstructured":"Campochiaro PA, et al. Neutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edema. Ophthalmology. 2014;121(9):1783\u201389.","DOI":"10.1016\/j.ophtha.2014.03.021"},{"issue":"2","key":"1648_CR12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ophtha.2014.08.048","volume":"122","author":"MS Ip","year":"2015","unstructured":"Ip MS, et al. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy. Ophthalmology. 2015;122(2):367\u201374.","journal-title":"Ophthalmology"},{"key":"1648_CR13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/OPTH.S118807","volume":"11","author":"L Ariana","year":"2017","unstructured":"Ariana L, Irene R, Anton O, et al. Retinal, reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections [J]. Clin Ophthalmol. 2017;11:193\u2013200.","journal-title":"Clin Ophthalmol"},{"key":"1648_CR14","doi-asserted-by":"crossref","first-page":"3989310","DOI":"10.1155\/2016\/3989310","volume":"2016","author":"JM Garcia","year":"2016","unstructured":"Garcia JM, et al. Diabetic macular ischemia diagnosis: comparison between optical coherence tomography angiography and fluorescein angiography. J Ophthalmol. 2016;2016:3989310.","journal-title":"J Ophthalmol"},{"issue":"4","key":"1648_CR15","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1364\/OE.20.004710","volume":"20","author":"Y Jia","year":"2012","unstructured":"Jia Y, et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express. 2012;20(4):4710\u201325.","journal-title":"Opt Express"},{"issue":"4","key":"1648_CR16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/ceo.12711","volume":"44","author":"ED Cole","year":"2016","unstructured":"Cole ED, et al. Contemporary retinal imaging techniques in diabetic retinopathy: a review. Clin Exp Ophthalmol. 2016;44(4):289\u201399.","journal-title":"Clin Exp Ophthalmol"},{"issue":"7","key":"1648_CR17","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s41433-019-0396-0","volume":"33","author":"X Ren","year":"2019","unstructured":"Ren X, et al. Safety and efficacy of intravitreal conbercept injection after vitrectomy for the treatment of proliferative diabetic retinopathy. Eye (Lond). 2019;33(7):1177\u201383.","journal-title":"Eye (Lond)"},{"key":"1648_CR18","doi-asserted-by":"crossref","unstructured":"Early Treatment Diabetic Retinopathy Study research group. Photocoagulation for diabetic macular edema: ETDRS report number 1. Arch Ophthalmol. 1985;103(12):1796\u2013806.","DOI":"10.1001\/archopht.1985.01050120030015"},{"issue":"5","key":"1648_CR19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.ophtha.2016.01.011","volume":"123","author":"M Larsen","year":"2016","unstructured":"Larsen M, et al. Individualized Ranibizumab regimen driven by stabilization criteria for central retinal vein occlusion: twelve-month results of the CRYSTAL study. Ophthalmology. 2016;123(5):1101\u201311.","journal-title":"Ophthalmology"},{"issue":"10","key":"1648_CR20","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1364\/BOE.7.003905","volume":"7","author":"A Camino","year":"2016","unstructured":"Camino A, et al. Evaluation of artifact reduction in optical coherence tomography angiography with real-time tracking and motion correction technology. Biomed Opt Express. 2016;7(10):3905\u201315.","journal-title":"Biomed Opt Express"},{"issue":"12","key":"1648_CR21","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1001\/jamaophthalmol.2016.4272","volume":"134","author":"TS Hwang","year":"2016","unstructured":"Hwang TS, Zhang M, Bhavsar K, et al. Visualization of 3 distinct retinal plexuses by projection-resolved optical coherence tomography angiography in diabetic retinopathy. JAMA Ophthalmol. 2016;134(12):1411\u20139.","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"1648_CR22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/IAE.0000000000002413","volume":"39","author":"C Lavia","year":"2019","unstructured":"Lavia C, et al. Vessel density of superficial, intermediate, and DEEP capillary plexuses using optical coherence tomography angiography. Retina. 2019;39(2):247\u201358.","journal-title":"Retina"},{"issue":"1","key":"1648_CR23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0002-9394(82)90197-0","volume":"94","author":"FR Ferris","year":"1982","unstructured":"Ferris FR, et al. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94(1):91\u20136.","journal-title":"Am J Ophthalmol"},{"issue":"Suppl 1","key":"1648_CR24","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1097\/IAE.0000000000001288","volume":"36","author":"J Schottenhamml","year":"2016","unstructured":"Schottenhamml J, et al. An automatic, intercapillary area-based algorithm for quantifying diabetes-related capillary dropout using optical coherence tomography angiography. Retina. 2016;36(Suppl 1):S93\u2013S101.","journal-title":"Retina"},{"issue":"4","key":"1648_CR25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/tvst.7.4.4","volume":"7","author":"BD Krawitz","year":"2018","unstructured":"Krawitz BD, et al. Parafoveal nonperfusion analysis in diabetic retinopathy using optical coherence tomography angiography. Transl Vis Sci Technol. 2018;7(4):4.","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"1648_CR26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000360909","volume":"232","author":"M Douvali","year":"2014","unstructured":"Douvali M, et al. Effect of macular ischemia on intravitreal ranibizumab treatment for diabetic macular edema. Ophthalmologica. 2014;232(3):136\u201343.","journal-title":"Ophthalmologica"},{"key":"1648_CR27","doi-asserted-by":"crossref","unstructured":"Liu Y, et al. Reversible retinal vessel closure from VEGF-induced leukocyte plugging. JCI Insight. 2017:2(18).","DOI":"10.1172\/jci.insight.95530"},{"key":"1648_CR28","doi-asserted-by":"crossref","unstructured":"El DY, et al. Reduced baseline diameter and contraction of peripheral retinal arterioles immediately after remote ischemia in diabetic patients. Graefes Arch Clin Exp Ophthalmol. 2019;257(10):2095\u2013101.","DOI":"10.1007\/s00417-019-04407-x"},{"issue":"6","key":"1648_CR29","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s13300-018-0527-9","volume":"9","author":"J Zhou","year":"2018","unstructured":"Zhou J, et al. Concentrations of VEGF and PlGF decrease in eyes after Intravitreal Conbercept injection. Diabetes Ther. 2018;9(6):2393\u20138.","journal-title":"Diabetes Ther"},{"issue":"6","key":"1648_CR30","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3390\/ijms19061636","volume":"19","author":"M Palmhof","year":"2018","unstructured":"Palmhof M, et al. Fewer functional deficits and reduced cell death after Ranibizumab treatment in a retinal ischemia model. Int J Mol Sci. 2018;19(6):1636.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1648_CR31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9440(10)63273-7","volume":"165","author":"T Inai","year":"2004","unstructured":"Inai T, et al. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol. 2004;165(1):35\u201352.","journal-title":"Am J Pathol"},{"issue":"13","key":"1648_CR32","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1158\/1078-0432.CCR-07-0278","volume":"13","author":"PV Dickson","year":"2007","unstructured":"Dickson PV, et al. Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy. Clin Cancer Res. 2007;13(13):3942\u201350.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1648_CR33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ajo.2014.03.009","volume":"158","author":"DA Sim","year":"2014","unstructured":"Sim DA, et al. Patterns of peripheral retinal and central macula ischemia in diabetic retinopathy as evaluated by ultra-widefield fluorescein angiography. Am J Ophthalmol. 2014;158(1):144\u201353 e1.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"1648_CR34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1167\/iovs.16-20579","volume":"58","author":"KG Falavarjani","year":"2017","unstructured":"Falavarjani KG, et al. Optical coherence tomography angiography analysis of the foveal avascular zone and macular vessel density after anti-VEGF therapy in eyes with diabetic macular edema and retinal vein occlusion. Invest Ophthalmol Vis Sci. 2017;58(1):30\u20134.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1648_CR35","doi-asserted-by":"publisher","unstructured":"Dastiridou A, et al. OCT Angiography Study of the Macula in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept [published online ahead of print, 2020 Jan 17]. Ocul Immunol Inflamm. 2020;1\u20136. https:\/\/doi.org\/10.1080\/09273948.2019.1704028.","DOI":"10.1080\/09273948.2019.1704028"},{"issue":"10","key":"1648_CR36","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1007\/s10792-019-01076-x","volume":"39","author":"OA Sorour","year":"2019","unstructured":"Sorour OA, et al. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy. Int Ophthalmol. 2019;39(10):2361\u201371.","journal-title":"Int Ophthalmol"},{"key":"1648_CR37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40942-019-0192-9","volume":"5","author":"FF Conti","year":"2019","unstructured":"Conti FF, et al. Changes in retinal and choriocapillaris density in diabetic patients receiving anti-vascular endothelial growth factor treatment using optical coherence tomography angiography. Int J Retina Vitreous. 2019;5:41.","journal-title":"Int J Retina Vitreous"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01648-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-020-01648-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01648-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T19:25:52Z","timestamp":1632511552000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01648-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,25]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1648"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01648-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.20427\/v1","asserted-by":"object"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,25]]},"assertion":[{"value":"19 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of the Second Xiangya Hospital of Central South University. All research was conducted in accordance with the Declaration of Helsinki, and all\u2002patients\u2002gave\u2002informed\u2002consent\u2002before\u2002participation\u2002in\u2002this\u2002study. Subjects were provided a written informed consent in accordance with the guidelines of the Second Xiangya Hospital of Central South University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"382"}}